Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nicorandil for Mitigation of Radiation Pneumonitis in Lung Cancer Patients
NCT02809456Phase 2Unknown
- Sponsor
- Taipei Medical University WanFang Hospital
- Start
- Jul 2016
- Primary completion
- Jul 2019
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of nicorandil in radiation pneumonitis (RP), sponsored by Taipei Medical University WanFang Hospital. Status: unknown.
02
Drugs
nicorandil
03
Conditions
radiation pneumonitis (RP)
Beyond the preview
Go deeper on NCT02809456.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02809456.